Suchergebnisse - "McMenamin, Martina"

PubPharm (21)

1

Increasing power in the analysis of responder endpoints in rheumatology: a software tutorial

enthalten in: bioRxiv.org | 2024

von McMenamin, M. | Grayling, M. | Berglind, A. | +1

2

Vaccine effectiveness of two and three doses of BNT162b2 and CoronaVac against COVID-19 in Hong Kong

enthalten in: bioRxiv.org | 2024

von McMenamin, M. | Nealon, J. | Lin, Y. | +6

3

Reported effectiveness of COVID-19 monovalent booster vaccines and hybrid immunity against mild and severe Omicron disease in adults : A systematic review and meta-regression analysis

enthalten in: Vaccine: X | 2024

von Nealon, J. | Mefsin, Y. | McMenamin, M. | +2

4

WHO Global Situational Alert System : a mixed methods multistage approach to identify country-level COVID-19 alerts

enthalten in: BMJ global health | 2023

von McMenamin, M. | Kolmer, J. | Djordjevic, I. | +85

5

The World Health Organization's public health intelligence activities during the COVID-19 pandemic response, December 2019 to December 2021

enthalten in: Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin | 2022

von Togami, E. | Griffith, B. | Mahran, M. | +36

6

Vaccine effectiveness of one, two, and three doses of BNT162b2 and CoronaVac against COVID-19 in Hong Kong : a population-based observational study

enthalten in: The Lancet. Infectious diseases | 2022

von McMenamin, M. | Nealon, J. | Lin, Y. | +6

ErratumIn: Lancet Infect Dis. 2022 Sep;22(9):e239. - PMID 35908551

7

Sample size estimation using a latent variable model for mixed outcome co-primary, multiple primary and composite endpoints

enthalten in: Statistics in medicine | 2022

von McMenamin, M. | Barrett, J. | Berglind, A. | +1

8

Estimation of Relative Vaccine Effectiveness in Influenza : A Systematic Review of Methodology

enthalten in: Epidemiology (Cambridge, Mass.) | 2022

von McMenamin, M. | Bond, H. | Sullivan, S. | +1

9

Improving power in PSA response analyses of metastatic castration-resistant prostate cancer trials

enthalten in: BMC cancer | 2022

von McMenamin, M. | Chandler, R. | Heer, R. | +1

10

Improving power in PSA response analyses of metastatic castration-resistant prostate cancer trials

enthalten in: BMC cancer | 2022

von Grayling, M. | McMenamin, M. | Chandler, R. | +2